Rheumatology

Uzm. Dr. Ozan Cemal İçaçan

Arthritis, RheumatoidLung Diseases, InterstitialScleroderma, SystemicBehcet Syndrome

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Arthritis, Rheumatoid 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Diseases, Interstitial 2 publications
  • Scleroderma, Systemic 2 publications
  • Behcet Syndrome 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyRheumatologysaglik.gov.trFrom source
  • InstitutionKanuni Sultan Süleyman Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workArthritis, RheumatoidExtracted from 3 publications · Model version —From source
  • Publications29 publicationsORCID, Europe PMC, OpenAlexFrom source
  • ORCID0000-0002-1054-5034ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://kanunieah.saglik.gov.tr/TR-1479041/doktorlarimiz.html#ozan-cemal-icacansaglik.gov.tr

Scientific work

Publications on Arthritis, Rheumatoid

29 publications
  1. Clinical Association of Pan-Immune-Inflammation Value with MEFV Mutation Burden and Amyloidosis in Adults with Familial Mediterranean Fever: A Retrospective Cohort Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15135058 PMID 42452521 Open-access full textSource: ORCID

  2. Association of serum Wnt1-inducible signaling pathway protein 1 (WISP1) levels with osteoarthritis and obesity-related inflammation in obese adults

    Scientific reports, 2026

    DOI 10.1038/s41598-026-52502-x PMID 42103993 Open-access full textSource: Europe PMC

  3. The Frequency and Effect of Scoliosis in Patients with Ankylosing Spondylitis

    Indian Journal of Rheumatology, 2025

    DOI 10.1177/09733698251314953 Open-access full textSource: OpenAlex

  4. IL-1 Inhibitors in the Treatment of Familial Mediterranean Fever: Treatment Indications and Clinical Features in a Large Real-World Cohort

    Journal of Clinical Medicine, 2024

    DOI 10.3390/jcm13123375 PMID 38929904 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/2h6ma1 PMID 37650346 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. Pulmonary involvement in antineutrophil cytoplasmic antibody-associated vasculitides: A single center experience from Turkey

    International journal of rheumatic diseases, 2023

    DOI 10.1111/1756-185x.14764 PMID 37287386 7 citations (Europe PMC) Open-access full textSource: Europe PMC

  7. Dermatomyositis associated with thymoma: A case report and literature review.

    PubMed, 2023

    DOI 10.7417/ct.2023.2506 PMID 36920126 4 citations (OpenAlex) Source: OpenAlex

  8. Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/ce13vk PMID 37470234 Open-access full textSource: OpenAlex

  9. Inverted grayscale in hand X-rays in patients with rheumatoid arthritis: A pilot study

    Ulusal Romatoloji Dergisi, 2023

    DOI 10.4274/raed.galenos.2023.80774 Open-access full textSource: OpenAlex

  10. Palpable purpura: is it associated with vasculitis or not? A single-center experience

    Clinical rheumatology, 2022

    DOI 10.1007/s10067-022-06075-5 PMID 35076788 2 citations (Europe PMC) Source: Europe PMC

View all 29 publications